131 related articles for article (PubMed ID: 38464025)
1. Discovery of the First-in-class G9a/GLP PROTAC Degrader.
Velez J; Han Y; Yim H; Yang P; Deng Z; Park KS; Kabir M; Kaniskan HÜ; Xiong Y; Jin J
bioRxiv; 2024 Feb; ():. PubMed ID: 38464025
[TBL] [Abstract][Full Text] [Related]
2. Discovery of the First-in-Class G9a/GLP PROTAC Degrader.
Velez J; Han Y; Yim H; Yang P; Deng Z; Park KS; Kabir M; Kaniskan HÜ; Xiong Y; Jin J
J Med Chem; 2024 Apr; 67(8):6397-6409. PubMed ID: 38602846
[TBL] [Abstract][Full Text] [Related]
3. Discovery of the First-in-Class G9a/GLP Covalent Inhibitors.
Park KS; Xiong Y; Yim H; Velez J; Babault N; Kumar P; Liu J; Jin J
J Med Chem; 2022 Aug; 65(15):10506-10522. PubMed ID: 35763668
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Potent and Selective Inhibitors for G9a-Like Protein (GLP) Lysine Methyltransferase.
Xiong Y; Li F; Babault N; Dong A; Zeng H; Wu H; Chen X; Arrowsmith CH; Brown PJ; Liu J; Vedadi M; Jin J
J Med Chem; 2017 Mar; 60(5):1876-1891. PubMed ID: 28135087
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a novel, highly potent EZH2 PROTAC degrader for targeting non-canonical oncogenic functions of EZH2.
Velez J; Dale B; Park KS; Kaniskan HÜ; Yu X; Jin J
Eur J Med Chem; 2024 Mar; 267():116154. PubMed ID: 38295690
[TBL] [Abstract][Full Text] [Related]
6. Structure-Based Design and Characterization of the Highly Potent and Selective Covalent Inhibitors Targeting the Lysine Methyltransferases G9a/GLP.
Feng Z; Yang C; Zhang Y; Li H; Fang W; Wang J; Nie Y; Wang CY; Liu Z; Jiang Z; Wang J; Wang Y
J Med Chem; 2023 Jun; 66(12):8086-8102. PubMed ID: 37268593
[TBL] [Abstract][Full Text] [Related]
7. Targeting H3K9 methyltransferase G9a and its related molecule GLP as a potential therapeutic strategy for cancer.
Rahman Z; Bazaz MR; Devabattula G; Khan MA; Godugu C
J Biochem Mol Toxicol; 2021 Mar; 35(3):e22674. PubMed ID: 33283949
[TBL] [Abstract][Full Text] [Related]
8. Discovery of an in vivo chemical probe of the lysine methyltransferases G9a and GLP.
Liu F; Barsyte-Lovejoy D; Li F; Xiong Y; Korboukh V; Huang XP; Allali-Hassani A; Janzen WP; Roth BL; Frye SV; Arrowsmith CH; Brown PJ; Vedadi M; Jin J
J Med Chem; 2013 Nov; 56(21):8931-42. PubMed ID: 24102134
[TBL] [Abstract][Full Text] [Related]
9. The Histone Methyltransferase Inhibitor A-366 Uncovers a Role for G9a/GLP in the Epigenetics of Leukemia.
Pappano WN; Guo J; He Y; Ferguson D; Jagadeeswaran S; Osterling DJ; Gao W; Spence JK; Pliushchev M; Sweis RF; Buchanan FG; Michaelides MR; Shoemaker AR; Tse C; Chiang GG
PLoS One; 2015; 10(7):e0131716. PubMed ID: 26147105
[TBL] [Abstract][Full Text] [Related]
10. Heterodimerization of H3K9 histone methyltransferases G9a and GLP activates methyl reading and writing capabilities.
Sanchez NA; Kallweit LM; Trnka MJ; Clemmer CL; Al-Sady B
J Biol Chem; 2021 Nov; 297(5):101276. PubMed ID: 34619147
[TBL] [Abstract][Full Text] [Related]
11. TNFα Effects on Adipocytes Are Influenced by the Presence of Lysine Methyltransferases, G9a (EHMT2) and GLP (EHMT1).
Able AA; Richard AJ; Stephens JM
Biology (Basel); 2023 Apr; 12(5):. PubMed ID: 37237488
[TBL] [Abstract][Full Text] [Related]
12. Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9.
Tachibana M; Ueda J; Fukuda M; Takeda N; Ohta T; Iwanari H; Sakihama T; Kodama T; Hamakubo T; Shinkai Y
Genes Dev; 2005 Apr; 19(7):815-26. PubMed ID: 15774718
[TBL] [Abstract][Full Text] [Related]
13. Zinc finger protein Wiz links G9a/GLP histone methyltransferases to the co-repressor molecule CtBP.
Ueda J; Tachibana M; Ikura T; Shinkai Y
J Biol Chem; 2006 Jul; 281(29):20120-8. PubMed ID: 16702210
[TBL] [Abstract][Full Text] [Related]
14. De novo methylation of histone H3K23 by the methyltransferases EHMT1/GLP and EHMT2/G9a.
Vinson DA; Stephens KE; O'Meally RN; Bhat S; Dancy BCR; Cole RN; Yegnasubramanian S; Taverna SD
Epigenetics Chromatin; 2022 Nov; 15(1):36. PubMed ID: 36411491
[TBL] [Abstract][Full Text] [Related]
15. Unexpected Distinct Roles of the Related Histone H3 Lysine 9 Methyltransferases G9a and G9a-Like Protein in Myoblasts.
Battisti V; Pontis J; Boyarchuk E; Fritsch L; Robin P; Ait-Si-Ali S; Joliot V
J Mol Biol; 2016 Jun; 428(11):2329-2343. PubMed ID: 27056598
[TBL] [Abstract][Full Text] [Related]
16. GLP overexpression is associated with poor prognosis in Chronic Lymphocytic Leukemia and its inhibition induces leukemic cell death.
Alves-Silva JC; de Carvalho JL; Rabello DA; Serejo TRT; Rego EM; Neves FAR; Lucena-Araujo AR; Pittella-Silva F; Saldanha-Araujo F
Invest New Drugs; 2018 Oct; 36(5):955-960. PubMed ID: 29855824
[TBL] [Abstract][Full Text] [Related]
17. G9a/GLP complexes independently mediate H3K9 and DNA methylation to silence transcription.
Tachibana M; Matsumura Y; Fukuda M; Kimura H; Shinkai Y
EMBO J; 2008 Oct; 27(20):2681-90. PubMed ID: 18818694
[TBL] [Abstract][Full Text] [Related]
18. Histone H3 lysine 9 methyltransferases, G9a and GLP are essential for cardiac morphogenesis.
Inagawa M; Nakajima K; Makino T; Ogawa S; Kojima M; Ito S; Ikenishi A; Hayashi T; Schwartz RJ; Nakamura K; Obayashi T; Tachibana M; Shinkai Y; Maeda K; Miyagawa-Tomita S; Takeuchi T
Mech Dev; 2013; 130(11-12):519-31. PubMed ID: 23892084
[TBL] [Abstract][Full Text] [Related]
19. G9a/GLP targeting in MM promotes autophagy-associated apoptosis and boosts proteasome inhibitor-mediated cell death.
De Smedt E; Devin J; Muylaert C; Robert N; Requirand G; Vlummens P; Vincent L; Cartron G; Maes K; Moreaux J; De Bruyne E
Blood Adv; 2021 May; 5(9):2325-2338. PubMed ID: 33938943
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the G9a/GLP histone methyltransferase complex modulates anxiety-related behavior in mice.
Wang DY; Kosowan J; Samsom J; Leung L; Zhang KL; Li YX; Xiong Y; Jin J; Petronis A; Oh G; Wong AHC
Acta Pharmacol Sin; 2018 May; 39(5):866-874. PubMed ID: 29417943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
